Inventor · disambiguated record
Emma L. Morris
Also filed as: MORRIS EMMA · MORRIS EMMA L
6 granted patents·2 pending applications·22 citations·filing 2013–2020
77Inventor score
Files withCANCER RESEARCH TECH LTD3IGNYTA INC2CANCER RES TECH LTD1UCL BUSINESS LTD1UCL BUSINESS PLC1
Top patents by PatentIndex Score
8 records- 0187US9604994B2Thienopyrimidine inhibitors of atypical protein kinase CCANCER RES TECH LTD·Filed 2014·Granted Mar 28, 2017·12 cites·26 claims
- 0282US9914730B2Azaquinazoline inhibitors of Atypical protein Kinase CIGNYTA INC·Filed 2013·Granted Mar 13, 2018·6 cites·13 claims
- 0382US9896446B2Azaquinazoline inhibitors of atypical protein kinase CIGNYTA INC·Filed 2015·Granted Feb 20, 2018·4 cites·14 claims
- 0464US10954251B2Thienopyrimidine inhibitors of atypical protein kinase CCANCER RESEARCH TECH LTD·Filed 2018·Granted Mar 23, 2021·0 cites·19 claims
- 0555US10183950B2Thienopyrimidine inhibitors of atypical protein kinase CCANCER RESEARCH TECH LTD·Filed 2017·Granted Jan 22, 2019·0 cites·10 claims
- 0647US2023226182A1Chimeric antigen receptor specific for hlaUCL BUSINESS LTD·Filed 2020·Application pending·0 cites
- 0734US2018371412A1Therapeutic t cellsUCL BUSINESS PLC·Filed 2016·Application pending·0 cites
- 0832US10414763B2Azaquinazoline inhibitors of atypical protein kinase CCANCER RESEARCH TECH LTD·Filed 2015·Granted Sep 17, 2019·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Emma L. Morris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →